Status:

COMPLETED

Treatment, Emotion, and Neuromodulation of Depression (TREND) Study

Lead Sponsor:

Erika Forbes

Conditions:

Depression

Eligibility:

All Genders

18-26 years

Phase:

NA

Brief Summary

The investigators will administer theta burst stimulation (TBS) in efforts to observe a decrease in severity of reported depression symptoms. A subset of participants will receive positive affect trai...

Detailed Description

The study has a longitudinal design in which participants complete a baseline assessment, 20 or 30 theta burst stimulation (TBS) sessions, a post-TBS assessment, and a follow-up assessment 4 months la...

Eligibility Criteria

Inclusion

  • Current Diagnostic and Statistical Manual (DSM-5) Depressive Disorder

Exclusion

  • Bipolar disorder (lifetime)
  • Obsessive-compulsive disorder (lifetime)
  • History of psychosis
  • Daily use of nicotine
  • Past-month use of cocaine, amphetamines, Methyl enedioxy methamphetamine (MDMA), Phencyclidine (PCP), Ketamine, or gamma-hydroxybutyrate (GHB)
  • Past 6 month substance use disorder
  • Binge drinking (using NIAAA criteria) within the past week, alcohol use in the past 12 hours
  • Neurological disorders: Epilepsy, Parkinson's Disease, brain tumor, brain injury, stroke
  • History of head trauma with a loss of consciousness (e.g., concussion)
  • History of seizures
  • MRI contraindications: body shape/size too large to fit in scanner, claustrophobia, and ferromagnetic metal in the body
  • Pregnancy
  • Current use of Clozapine, Bupropion, or prescription stimulants
  • Current use of benzodiazepines or mood stabilizers
  • Body shape/size too large to fit in MRI scanner
  • Claustrophobia
  • Metal in the head or ferromagnetic metal in the rest of the body
  • Implanted medical devices
  • High-risk suicidality

Key Trial Info

Start Date :

June 17 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 30 2025

Estimated Enrollment :

21 Patients enrolled

Trial Details

Trial ID

NCT05436379

Start Date

June 17 2022

End Date

November 30 2025

Last Update

December 30 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The University of Pittsburgh, Department of Psychiatry

Pittsburgh, Pennsylvania, United States, 15213